---
link: https://news.google.com/rss/articles/CBMiREFVX3lxTE9ZV0JhaWpWRGxYUVQ4SExTQ25iU3VadWJ4S3VQS1A5ckl0cHlzZk1VS2tjVVozNmozRmxRUG5mb0JSc1Uz?oc=5
author: 
published: Tue, 23 Dec 2025 00:25:00 GMT
tags: [News, Google, 경제]
---
# HER2 양성 유방암 환자, 난소기능 억제로 생존율 향상 가능성 확인 - 후생신보

[원문 링크](https://news.google.com/rss/articles/CBMiREFVX3lxTE9ZV0JhaWpWRGxYUVQ4SExTQ25iU3VadWJ4S3VQS1A5ckl0cHlzZk1VS2tjVVozNmozRmxRUG5mb0JSc1Uz?oc=5)

## 요약/본문
<ol><li><a href="https://news.google.com/rss/articles/CBMiREFVX3lxTE9ZV0JhaWpWRGxYUVQ4SExTQ25iU3VadWJ4S3VQS1A5ckl0cHlzZk1VS2tjVVozNmozRmxRUG5mb0JSc1Uz?oc=5" target="_blank">HER2 양성 유방암 환자, 난소기능 억제로 생존율 향상 가능성 확인</a>&nbsp;&nbsp;<font color="#6f6f6f">후생신보</font></li><li><a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE9USmxtR1NTVm9BR3ZlRWw5NFV5SktQUk9kemNSLW1JZC1VcnVySDhqall4UXhOc2FLRFBvTjdMd0dwckI1SFdtTHhiMVNScFU?oc=5" target="_blank">젊은 유방암 환자 치료 전략 바뀌나… 난소기능 억제로 생존율 향상</a>&nbsp;&nbsp;<font color="#6f6f6f">v.daum.net</font></li><li><a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE5jREVRNFoxT2RTZFI2bEN5c2t3QzlpVm1ZYkp3c044ZlVuYm1aYUp2dEU5NXN2WW1NWTBvbl9nUlpSMXE0bjlvZ0tQQUo3U0NMMTlXcDFIRWVZRjVhSFFxbTF6Z27SAXhBVV95cUxPN2d2b295eGEtWEJuSnBRM2hWc0Z0Yk5Pa1F4Zkpka19hX0RQS1ZrSDhad245Y0tkOHFxeXVKeEdqYlRaRHVudG1LQ1hkVllvZXFPa19uTE5xamE4YkVDUlJNb0JRb3Ayc3VPVGUxTjJBTDhTbUtqZmU?oc=5" target="_blank">호르몬 양성 유방암 환자…'이 치료' 병행시 재발 32%↓</a>&nbsp;&nbsp;<font color="#6f6f6f">뉴시스</font></li><li><a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1JaUxwczBrVmp6bjd6N2VESnFpX2toUmNtZU9EMi1XcVJ3b01rS2RXZUJOZnJ3MVFqVVlDN1U5bHBlTlgwUXhnUXNRZ21faTdSMHAw?oc=5" target="_blank">강남세브란스 "HR·HER2 양성 유방암 환자, 난소기능 억제제 도움"</a>&nbsp;&nbsp;<font color="#6f6f6f">네이트</font></li><li><a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFBBejNHYlZzS3R2dEdNQUdEOEFyRGZtV3JwbExPU21uRHZhTDJQb0JMbG0zQllFRkJmUjVSWURQV2pwMXczMDBoaUJtdGVqY3lQUU1Ud0Z3?oc=5" target="_blank">[김태열의 생생건강S펜] “HR·HER2 모두 양성 유방암 환자, 난소기능억제제 병행시 생존율 획기적으로 높여”</a>&nbsp;&nbsp;<font color="#6f6f6f">헤럴드경제</font></li></ol>
